tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GILD Stock Latest News

3 Best ETFs to Invest In, According to AI Analyst, 03/10/2026
Market News3 Best ETFs to Invest In, According to AI Analyst, 03/10/2026
16h ago
JNJ
MRK
Gilead initiated with a Buy at Jefferies
PremiumThe Fly
Gilead initiated with a Buy at Jefferies
1d ago
GILD
The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
3d ago
AA
DG
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
PremiumRatings
Gilead Sciences: Advancing Long-Acting HIV Franchise Underscores Competitive Edge and Supports Buy Rating
13d ago
GILD
Gilead presents new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data
PremiumThe Fly
Gilead presents new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data
14d ago
GILD
Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
PremiumRatingsGilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
14d ago
GILD
Qualcomm, Booking Holdings upgraded: Wall Street’s top analyst calls
Premium
The Fly
Qualcomm, Booking Holdings upgraded: Wall Street’s top analyst calls
15d ago
BE
DPZ
Arcellx downgraded to Hold from Buy at Stifel
Premium
The Fly
Arcellx downgraded to Hold from Buy at Stifel
15d ago
ACLX
GILD
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
16d ago
AMC
AMD
Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
PremiumMarket News
Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
16d ago
ACLX
GILD
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
PremiumThe Fly
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
16d ago
D
DE
Alphabet, Nvidia upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alphabet, Nvidia upgraded: Wall Street’s top analyst calls
16d ago
DE
BLK
M&A News: Arcellx Stock (ACLX) Booms 70% after Gilead Buys Cancer-Fighting Biotech for $7.8B
PremiumMarket NewsM&A News: Arcellx Stock (ACLX) Booms 70% after Gilead Buys Cancer-Fighting Biotech for $7.8B
16d ago
ACLX
GILD
Gilead Sciences to Acquire Arcellx in Major Cell-Therapy Deal
Premium
Company Announcements
Gilead Sciences to Acquire Arcellx in Major Cell-Therapy Deal
16d ago
8K
GILD
Gilead to acquire Arcellx for $115 per share in cash at closing, or $7.8B
Premium
The Fly
Gilead to acquire Arcellx for $115 per share in cash at closing, or $7.8B
16d ago
ACLX
GILD
Gilead to acquire Arcellx for $115 per share in cash at closing, or $7.8B
PremiumThe Fly
Gilead to acquire Arcellx for $115 per share in cash at closing, or $7.8B
16d ago
ACLX
GILD
Gilead initiated with an Equal Weight at Barclays
PremiumThe Fly
Gilead initiated with an Equal Weight at Barclays
20d ago
GILD
Gilead price target raised to $170 from $140 at Mizuho
PremiumThe Fly
Gilead price target raised to $170 from $140 at Mizuho
20d ago
GILD
Gilead Sciences: Strong HIV Growth Priced In, Diversification Still Limited Justifying Hold Rating
PremiumRatings
Gilead Sciences: Strong HIV Growth Priced In, Diversification Still Limited Justifying Hold Rating
21d ago
GILD
Gilead price target raised to $175 from $155 at UBS
PremiumThe FlyGilead price target raised to $175 from $155 at UBS
21d ago
GILD
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
Premium
Market News
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
22d ago
IBB
UPB
Gilead Sciences Earnings Call: HIV Strength, New Catalysts
Premium
Company Announcements
Gilead Sciences Earnings Call: HIV Strength, New Catalysts
27d ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >